Navigation Links
Lilly Announces Dividend Increase
Date:12/15/2008

INDIANAPOLIS, Dec. 15 /PRNewswire-FirstCall/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today announced a 4.3 percent increase in its quarterly dividend. The board declared a dividend for the first quarter of 2009 of $0.49 per share on outstanding common stock. This raises the annual indicated rate to $1.96 per share and represents the 42nd consecutive year in which the company has increased the dividend payment.

The dividend is payable March 10, 2009, to shareholders of record at the close of business on February 13, 2009.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. F-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Lillys CEO Calls for Reform of Nations Drug Safety System
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
8. Lilly Delivers Strong Third-Quarter Results
9. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
10. Eli Lilly and Company Aids California Recovery Effort
11. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Recently, iFitDress.com, the distinguished wedding dress manufacturer and ... bridesmaid dresses . Included in the new range are ... them are provided at deeply discounted prices, from 22 ... fast and reliable delivery service. All clients from around ... short time. As is commonly noted, international customers have ...
(Date:8/28/2014)... about the chance of ,overdiagnosis, through the NHS breast ... according to research published in the British Journal ... survey of around 2,200 women, Cancer Research UK scientists ... cent felt they fully understood the information given about ... cancers that would never have gone on to cause ...
(Date:8/28/2014)... Blood's Thicker Than Water is based on ... ties in the heart of the city. Raymond E. Blake ... about how disrespect caused two families to collide with each ... The Yayo Boyz and the M.O.B. Boyz clash in a ... onlookers in a silent terror. "Guerrilla," AKA "Real," runs his ...
(Date:8/28/2014)... August 28, 2014 Millennium Treatment Group recently ... is extremely large, and Millennium Treatment Group is working to ... that they need. , According to the National Survey ... 21 million Americans could have benefited from treatment for drug ... received help. This means that there is a large treatment ...
(Date:8/28/2014)... 2014 Millennium Treatment Group has noticed ... the workplace. A recent report from the National ... that drug abuse is costing employers an estimated $81 ... addicted to drugs affect their employers and the company ... the workplace, causing expensive problems for their employers, such ...
Breaking Medicine News(10 mins):Health News:New Selection of Chic Bridesmaid Dresses Available at iFitDress.com 2Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Millennium Treatment Group Works to Close Treatment Gap 2Health News:Drug Use Causes Problems in the Workplace 2
... ... business markets are finding doeBilling™ solutions can help them control their outside legal ... budgeting, and forecasting. Make smarter, faster decisions. , ... Wilmington, Delaware (PRWEB) March 25, 2010 ...
... ... care documentation for Military Health System personnel across the Department of Defense Enterprise ... Scottsdale, AZ ... workflow solutions, has been chosen to supply clinical workflow technology to the Department of ...
... Teenage ... and retreats. , ... (PRWEB) March 24, 2010 -- Centaur Arabian Farms, a bed and breakfast on 10 acres ... retreats on a smaller scale., , ,“We plan to finish the landscaping and construction soon ...
... reported to control the diarrhea that can accompany chemotherapy. ... anal or rectal cancers, the drug proved no better ... published online March 24 in the Journal of ... given concurrently, are standard treatments for anorectal cancers, which ...
... to people living with HIV in clinical settings can sharply ... now in the online edition of the journal " AIDS ... upcoming print issue. "We found the greatest and most ... interventions were delivered by medical care providers during HIV patients, ...
... The occurrence ... in patients with osteoporosis, including those treated with the drug family known as bisphosphonates, according to ... ... unusual type of fracture of the femur, or the thigh bone, is very low in patients ...
Cached Medicine News:Health News:doeLegal Penetrates New Markets With doeBilling Solution 2Health News:Carefx to Provide Clinical Workflow Solutions for Military Health System 2Health News:Centaur Arabian Farms Expands Facilities to Offer New Wedding and Event Venue in East Texas 2Health News:UCSF study finds clinic-based HIV prevention is effective in reducing risk behaviors 2Health News:Benefits of Osteoporosis Treatments Outweigh Possible Risk of Rare Femoral Fractures 2Health News:Benefits of Osteoporosis Treatments Outweigh Possible Risk of Rare Femoral Fractures 3Health News:Benefits of Osteoporosis Treatments Outweigh Possible Risk of Rare Femoral Fractures 4
(Date:8/28/2014)... , Aug. 28, 2014 ... research report is available in its ... and Compliance Services Industry (U.S.): Analytics, ... Forecasts to 2021, NAIC 541380 ... Testing Laboratories, Safety and ...
(Date:8/28/2014)... Mass. , Aug. 28, 2014  Decision ... system market will grow strongly through 2022 at ... percent. This will be largely supported by strong ... will increase demand for imaging procedures. The Indian ... allow more facilities to purchase or upgrade diagnostic ...
(Date:8/28/2014)... 28, 2014 Takeda Pharmaceutical Company Limited ... and submissions of data from a 10-year epidemiology ... United States (U.S.) Food and Drug ... the Japanese Ministry of Health, Labour, and Welfare ... Agency (PMDA) for pioglitazone containing medicines, including ACTOS ...
Breaking Medicine Technology:Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 2Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 4Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 6
... People recovering,from acute heart problems such as ... develop habits to control heart attack risk factors ... to researchers at,Mayo Clinic in Rochester. These managers ... programs that last,three years. With these risk factors ...
... 4 AstraZeneca (NYSE:,AZN) today announced that it ... U.S. Food and Drug Administration (FDA) for approval ... Aerosol for the long-term maintenance treatment of asthma ... SYMBICORT is currently approved,for the long-term maintenance treatment ...
Cached Medicine Technology:Heart Patients More Likely to Adopt Healthy Habits in 3-Year Program Led by Cardiac Rehabilitation Experts, Mayo Clinic Research Shows 2Heart Patients More Likely to Adopt Healthy Habits in 3-Year Program Led by Cardiac Rehabilitation Experts, Mayo Clinic Research Shows 3Heart Patients More Likely to Adopt Healthy Habits in 3-Year Program Led by Cardiac Rehabilitation Experts, Mayo Clinic Research Shows 4AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 2AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 3AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 4AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 5AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 6
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: